Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease

Table 1 Characteristics of the participants

Variable	Control group (n = 13)	Case group (n = 19)
Demographics
Gender [n (%)]	12 (92.3%) M, 1 (7.7%) F	10 (52.6%) M, 9 (47.4%) F
Age (years)	42.50 ± 16.8	65.8 ± 10.4
Physical characteristics
Weight (kg)	82.5 ± 8.7	75.1 ± 10.6
Height (cm)	177.8 ± 9.0	169.3 ± 7.3
Body mass index (kg/m²)	26.1 ± 2.1	26.2 ± 3.3
Clinical information [n (%)]
Hypertension	2 (15.4%)	18 (94.7%)
Obesity	1 (7.7%)	2 (10.5%)
Diabetes	0 (0%)	5 (26.3%)
Dyslipoproteinemia	0 (0%), 1 (7.7%) NA	2 (10.5%)
Left ventricular hypertrophy	1 (7.7%)	6 (31.6%)
Angina pectoris	0 (0%)	1 (5.3%)
Intermittent claudication	0 (0%), 1 (7.7%) NA	7 (36.8%)
Myocardial infarction	0 (0%)	3 (15.8%)

For gender: M male, F female. Hypertension occurrence corresponds to systolic blood pressure ≥ 140/90 mmHg. Obesity is defined by a body mass index > 30 kg/m². For dyslipoproteinemia all the following measurements have to occur: total cholesterol ≥ 5.2 mmol/l (≥ 200 mg/dl); low-density lipoprotein (LDL) cholesterol ≥ 3.4 mmol/l (≥ 130 mg/dl); high-density lipoproteins (HDL) cholesterol ≤ 1.0 mmol/l (≤ 40 mg/dl); and triglycerides ≥ 1.7 mmol/l (≥ 150 mg/dl)
NA not available data

ISSN: 1479-5876